Boxes of Ozempic and Wegovy at a pharmacy in London, England, March 8, 2024. (Hollie Adams/Reuters)
One of the (many) reasons that central planning fails is because of the difficulty of forecasting the countless consequences of some event, innovation, or other development, even one so small as that much quoted flap of the butterfly's wing.
And so, via the Wall Street Journal,here's one example, admittedly more predictable than most.
America’s apparel companies are fighting increasing returns. The problem is the soaring use of weight-loss drugs. . . . Shoppers are increasingly buying multiple versions of the same garment, and then sending back those that don’t fit. They are also sizing down through exchanges, returning larger sizes in favor
...
Continue reading this article with an NRPLUS subscription.
